MOORFIELD HOUSE SURGERY — All Prescriptions & Medications — Page 3
Practice Code: B86658 | LEEDS, LS25 1AN
Showing results 101-150 of 619
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Mometasone furoate | 487 | 575 | £4.4K | +21.3% ▲ |
| Betamethasone valerate | 480 | 33.3K | £1.9K | +24.7% ▲ |
| Loperamide hydrochloride | 468 | 66.7K | £11.5K | +100.9% ▲ |
| Fluticasone/umeclidinium/vilanterol | 454 | 503 | £21.3K | +93.7% ▲ |
| Zopiclone | 454 | 9,948 | £404 | -18.0% ▼ |
| Fluticasone furoate | 447 | 481 | £3.1K | +130.8% ▲ |
| Esomeprazole | 435 | 19.8K | £2.8K | +7.5% ▲ |
| Beclometasone dipropionate | 426 | 435 | £1.3K | +98.1% ▲ |
| Phenoxymethylpenicillin (Penicillin V) | 421 | 32.2K | £1.3K | +37.4% ▲ |
| Estradiol with progestogen | 417 | 15.8K | £13.9K | +22.4% ▲ |
| Combined ethinylestradiol 30mcg | 415 | 44.2K | £2.4K | +49.4% ▲ |
| 410 | 522 | £601 | +86.1% ▲ | |
| Other multivitamin preparations | 396 | 10.5K | £3.3K | +129.2% ▲ |
| Sumatriptan succinate | 393 | 3,191 | £4.3K | +11.0% ▲ |
| Carbamazepine | 393 | 30.5K | £1.6K | +32.4% ▲ |
| Empagliflozin | 388 | 15.9K | £19.7K | -38.0% ▼ |
| Quinine sulfate | 386 | 10.2K | £1.6K | +33.3% ▲ |
| Eplerenone | 379 | 11.7K | £1.5K | +42.9% ▲ |
| Diclofenac diethyl | 378 | 44.3K | £2.6K | +6.4% ▲ |
| Quetiapine | 377 | 18.5K | £8.8K | -39.4% ▼ |
| Hydroxychloroquine sulfate | 377 | 14.9K | £730 | +94.7% ▲ |
| Sacubitril/valsartan | 370 | 16.3K | £26.6K | +54.5% ▲ |
| Glyceryl trinitrate | 368 | 573 | £930 | +55.6% ▲ |
| Estradiol | 368 | 9,404 | £4.9K | +36.4% ▲ |
| 365 | 372 | £1.9K | +54.5% ▲ | |
| Donepezil hydrochloride | 363 | 10.4K | £3.0K | +17.6% ▲ |
| Insulin aspart | 363 | 2,131 | £15.3K | -4.7% ▼ |
| 345 | 62.6K | £2.7K | +59.5% ▲ | |
| Lactulose | 344 | 172.9K | £1.8K | +4.5% ▲ |
| Sodium valproate | 342 | 60.5K | £5.5K | +7.5% ▲ |
| Clarithromycin | 337 | 8,712 | £1.5K | +37.3% ▲ |
| Linagliptin | 331 | 7,455 | £8.4K | -19.2% ▼ |
| Oxybutynin | 329 | 19.0K | £2.8K | +72.7% ▲ |
| Risperidone | 327 | 8,647 | £773 | +29.3% ▲ |
| Baclofen | 327 | 51.4K | £893 | +63.2% ▲ |
| Atenolol | 324 | 13.9K | £303 | -46.3% ▼ |
| Tirzepatide | 321 | 333 | £31.0K | +65.3% ▲ |
| Betahistine hydrochloride | 320 | 29.6K | £1.2K | +34.0% ▲ |
| Aciclovir | 319 | 12.2K | £634 | +114.5% ▲ |
| Timolol and bimatoprost | 317 | 5,193 | £6.3K | +108.9% ▲ |
| Dihydrocodeine tartrate | 315 | 29.8K | £1.9K | +61.2% ▲ |
| Loratadine | 314 | 16.1K | £389 | +50.3% ▲ |
| Hyoscine butylbromide | 308 | 27.5K | £2.3K | +32.2% ▲ |
| Mesalazine (Systemic) | 295 | 31.6K | £16.8K | +23.1% ▲ |
| Enalapril maleate | 293 | 15.1K | £617 | +63.1% ▲ |
| Topiramate | 293 | 16.5K | £1.9K | +64.9% ▲ |
| 288 | 36.4K | £1.5K | +119.8% ▲ | |
| Tolterodine | 287 | 10.7K | £1.4K | +93.0% ▲ |
| Prochlorperazine maleate | 284 | 14.4K | £864 | +40.5% ▲ |
| Promethazine hydrochloride | 283 | 10.7K | £1.4K | -20.8% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.